Century Therapeutics Inc. (NASDAQ: IPSC)
$3.25
+0.5000 ( +18.18% ) 387.0K
Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.
Market Data
Open
$3.25
Previous close
$2.75
Volume
387.0K
Market cap
$278.01M
Day range
$2.76 - $3.34
52 week range
$1.28 - $5.51
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 47 | Jul 08, 2024 |
8-k/a | 8K-related | 19 | Jun 26, 2024 |
4 | Insider transactions | 1 | Jun 24, 2024 |
8-k | 8K-related | 13 | Jun 24, 2024 |
4 | Insider transactions | 2 | Jun 21, 2024 |
4 | Insider transactions | 2 | Jun 21, 2024 |
4 | Insider transactions | 2 | Jun 21, 2024 |
4 | Insider transactions | 2 | Jun 21, 2024 |
4 | Insider transactions | 2 | Jun 21, 2024 |
4 | Insider transactions | 2 | Jun 21, 2024 |